Genital herpes in obstetrics and neonatal herpes (literature review)

Authors

DOI:

https://doi.org/10.15574/HW.2024.6(175).7482

Keywords:

genital herpes, primary episode, recurrence, mother-to-child transmission, suppressive antiviral therapy, neonatal herpes

Abstract

Genital herpes (GH) is a chronic infection caused by herpes simplex virus (HSV) types 1 and 2, which is mainly sexually transmitted and causes recurrent genital ulcers throughout life. Infection of a woman with HSV during pregnancy poses a risk to the development of the fetus and newborn. Transmission of the virus occurs through contact with HSV type 1 or 2 in the prenatal period, during the intrapartum period, or after delivery.

The aim is to review the clinical forms of HSV infection in pregnant women and newborns, ways of mother-to-child transmission, current approaches to diagnosis and treatment, indications for cesarean section, and ways of prevention in uninfected women during pregnancy and in healthy infants.

The literature search was conducted using PubMed/MEDLINE, Google, the Cochrane Library, international recommendations and guidelines for 2014-2025. The clinical diagnosis of GH is usually made by detecting vesicular, eroded, or ulcerated lesions, but should always be confirmed by laboratory tests. The approach to antiviral therapy in pregnant women with GH takes into account the classification of the infection, the severity of symptoms and the gestational age at the time of infection in relation to the term of delivery. Suppressive antiviral therapy is used to reduce the likelihood of recurrence of GH before delivery. Despite progress in diagnosis, treatment, and prevention, neonatal herpes infection continues to cause significant morbidity and mortality in newborns.

No conflict of interests was declared by the author.

References

ACOG. (2020). Management of Genital Herpes in Pregnancy. ACOG Practice Bulletin Summary, Number 220. Obstet Gynecol. 135(5): 1236-1238. https://doi.org/10.1097/AOG.0000000000003841; PMid:32332408

Aggerholm BS, Ostenfeld EB, Andersen LHJ, Krogh RHA, Arendt LH, Sandager P. (2020). Genital herpes simplex virus infection in pregnancy. Ugeskr Laeger. 182(5): V09190527. URL: https://pubmed.ncbi.nlm.nih.gov/32052736/.

Batteiger TA, Rietmeijer CA. (2024, Mar). Herpes Simplex Virus: A Practical Guide to Diagnosis, Management, and Patient Counseling for the Primary Care Clinician. Med Clin North Am. 108(2): 311-323. https://doi.org/10.1016/j.mcna.2023.08.016; PMid:38331482

Bohl TG. (2017, Sep). Fissures, Herpes Simplex Virus, and Drug Reactions: Important Erosive Vulvar Disorders. Obstet Gynecol Clin North Am. 44(3): 421-443. https://doi.org/10.1016/j.ogc.2017.05.005; PMid:28778641

Canadian Agency for Drugs and Technologies in Health. (2014). Acyclovir versus valacyclovir for herpes virus in children and pregnant women: a review of the clinical evidence and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. URL: https://www.ncbi.nlm.nih.gov/books/NBK253720/.

Clarke E, Patel R, Dickins D et al. (2025). Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update). Int J STD AIDS. 36(1): 4-23. https://doi.org/10.1177/09564624241280734; PMid:39348176

Egan K, Hook LM, LaTourette P, Desmond A, Awasthi S, Friedman HM. (2020, Jun). Vaccines to prevent genital herpes. Transl Res. 220: 138-152. https://doi.org/10.1016/j.trsl.2020.03.004; PMid:32272093 PMCid:PMC7293938

Feltner C, RTI International-University of North Carolina Evidence-based Practice Center, United States. Agency for Healthcare Research and Quality, U.S. (2016). Preventive Services Task Force. Serological screening for genital herpes: an evidence review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality. URL: https://www.ncbi.nlm.nih.gov/books/NBK409117/.

Foley E, Patel R. (2022). Genital ulceration. Medicine. 50(5): 266-271. https://doi.org/10.1016/j.mpmed.2022.02.004

Heggarty E, Sibiude J, Mandelbrot L, Vauloup-Fellous C, Picone O. (2020). Genital herpes and pregnancy: Evaluating practices and knowledge of French health care providers. Eur J Obstet Gynecol Reprod Biol. 249: 84-91. https://doi.org/10.1016/j.ejogrb.2020.02.039; PMid:32122691

Jeffery-Smith A, Riddell A. (2021). Herpesviruses. Medicine. 49(12): 780-784. https://doi.org/10.1016/j.mpmed.2021.09.011

Joseph NT, Banga J, Badell ML. (2023, Mar). An Overview of Antiviral Treatments in Pregnancy. Obstet Gynecol Clin North Am. 50(1): 183-203. https://doi.org/10.1016/j.ogc.2022.10.017; PMid:36822703

Jurga J, Sawczynska K, Bosak M, Jaworowski A, Slowik A, Huras H. (2023, Aug 21). Herpes simplex encephalitis in pregnancy. Ginekol Pol. Epub ahead of print. PMID: 37599570. https://doi.org/10.5603/gpl.95204; PMid:37599570

Mehrmal S, Mojica R, Guo AM, Missall TA. (2024, Feb). Diagnostic Methods and Management Strategies of Herpes Simplex and Herpes Zoster Infections. Clin Geriatr Med. 40(1): 147-175. https://doi.org/10.1016/j.cger.2023.09.003; PMid:38000858

Money DM, Steben M. (2017). No. 208 Guidelines for the Management of Herpes Simplex Virus in Pregnancy. J Obstet Gynaecol Can. 39(8): e199-e205. https://doi.org/10.1016/j.jogc.2017.04.016; PMid:28729112

Money D, Steben M. (2017). No. 207. Genital Herpes: Gynaecological Aspects. J Obstet Gynaecol Can. 39(7): e105-e11. https://doi.org/10.1016/j.jogc.2017.04.015; PMid:28625289

MOZ Ukrainy. (2022). Pro zatverdzhennia Unifikovanoho klinichnoho protokolu pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Kesariv roztyn». Nakaz MOZ Ukrainy vid 05.01.2022 roku No. 8.

Mrozik A, Sellier Y, Lemaitre D, Gaucher L. (2023). Evaluation of Midwives' Practises on Herpetic Infections during Pregnancy: A French Vignette-Based Study. Healthcare (Basel). 28; 11(3): 364. https://doi.org/10.3390/healthcare11030364; PMid:36766939 PMCid:PMC9914294

Mularoni A, Cona A, Ribeiro Dias L, Bulati M, Busà R, Castelbuono S et al. (2024, Feb). Cytokine storm and severe hepatitis in pregnancy due to herpes simplex virus 2. 52(1): 259-263. https://doi.org/10.1007/s15010-023-02092-x; PMid:37759073 PMCid:PMC10811078

Ngalame AN, Mubiana-Mbewe M, Dionne JA.(2022). Genital Tract Infections in Women, Pregnancy and Neonates. Obstet Gynecol Clin North Am. 49(4): 751-769. https://doi.org/10.1016/j.ogc.2022.07.004; PMid:36328678

Omarova S, Cannon A, Weiss W, Bruccoleri A, Puccio J. (2022). Genital Herpes Simplex Virus - An Updated Review. Adv Pediatr. 69(1): 149-162. https://doi.org/10.1016/j.yapd.2022.03.010; PMid:35985707

Patel R, Moran B, Clarke E, Geretti A, Lautenschlager S, Green J et al. (2024). 2024 European guidelines for the management of genital herpes. URL: https://iusti.org/wp-content/uploads/2023/10/IUSTI-Guidelines-2024-Final-version-for-Circulation-.docx. https://doi.org/10.1111/jdv.20450; PMid:39620271

Riley L, Wald A. (2022). Genital herpes simplex virus infection and pregnancy. URL: http://surl.li/pjdak.

Rogan SC, Beigi RH. (2021). Management of Viral Complications of Pregnancy: Pharmacotherapy to Reduce Vertical Transmission. Obstet Gynecol Clin North Am. 48(1): 53-74. https://doi.org/10.1016/j.ogc.2020.12.001; PMid:33573790

Rogan SC, Beigi RH. (2019). Treatment of Viral Infections During Pregnancy. Clin Perinatol. 46(2): 235-256. https://doi.org/10.1016/j.clp.2019.02.009; PMid:31010558

Schalkwijk HH, Snoeck R, Andrei G. (2022). Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives. Biochemical Pharmacology. 206: 115322. https://doi.org/10.1016/j.bcp.2022.115322; PMid:36309081

Sénat MV, Anselem O, Picone O, Renesme L, Sananès N, Vauloup-Fellous C et al. (2018). Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 224: 93-101. https://doi.org/10.1016/j.ejogrb.2018.03.011; PMid:29571124

Shi T-l, Huang L-J, Xiong Y-Q, Zhong Y-Y, Yang J-J, Fu T et al. (2018). The risk of herpes simplex virus and human cytomegalovirus infection during pregnancy upon adverse pregnancy outcomes: A meta-analysis. J Clin Virol. 104: 48-55. https://doi.org/10.1016/j.jcv.2018.04.016; PMid:29729547

Sindhuja T, Gupta V, Bhari N, Gupta S. (2021). Asian guidelines for genital herpes. J Infect Chemother. 27(10): 1389-1399. https://doi.org/10.1016/j.jiac.2021.07.015; PMid:34332884

Stephenson-Famy A, Gardella C. (2014). Herpes Simplex Virus Infection During Pregnancy. Obstet Gynecol Clin North Am. 41(4): 601-614. https://doi.org/10.1016/j.ogc.2014.08.006; PMid:25454993

Sviatenko TV, Zakharova SV et al. (2024). Urohenitalni infektsii. Pidruchnyk. Za red.: Sviatenko T.V., Zakharova S.V. Vinnytsia: Nova knyha: 416.

Van Wagoner N, Qushair F, Johnston C. (2023). Genital Herpes Infection: Progress and Problems. Infect Dis Clin North Am. 37(2): 351-367. https://doi.org/10.1016/j.idc.2023.02.011; PMid:37105647

Workowski KA, Bachmann LH, Chan PA et al. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 23; 70(4): 1-187. https://doi.org/10.15585/mmwr.rr7004a1; PMid:34292926 PMCid:PMC8344968

Published

2024-12-15